Tag: CX 2018

One-year results of ACCESS PTS study brings “hope” for post-thrombotic syndrome...

The one-year results of the ACCESS PTS trial have shown that EKOS therapy (BTG) statistically improves post-thrombotic syndrome scores and sequelae as well as...

Changes to lumen shape may be more important than area in...

Data presented at the Charing Cross Symposium (24–27 April, London, UK) indicate that a rounder post-stent lumen shape has a positive correlation to 12-month...

CX audience rejects idea that ATTRACT has the final say on...

According to a debate at the Charing Cross Symposium (CX; 24–27 April, London, UK), the vast majority of CX delegates disagree with the view...

Landmark EVRA trial provides first Level 1 evidence for early endovenous...

The first full results of the Early Venous Reflux Ablation (EVRA) ulcer study were presented at the Charing Cross Symposium (CX; 24-27 April, London,...